Cargando…

Elevated HMGB1 promotes the malignant progression and contributes to cisplatin resistance of non-small cell lung cancer

BACKGROUND: HMGB1 (high mobility group box B-1) exhibits crucial role in tumor genesis and development, including lung cancer. Whereas, more HMGB1-related details in non-small cell lung cancer (NSCLC) are still largely unclear. METHODS: The HMGB1 and inflammatory factors in malignant (MPE) and non-m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Ying, Feng, Qin, Han, Bateer, Yu, Rong, Jin, Zhiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388484/ https://www.ncbi.nlm.nih.gov/pubmed/37518006 http://dx.doi.org/10.1186/s41065-023-00294-9

Ejemplares similares

Hypoxia-elevated circELP3 contributes to bladder cancer progression and cisplatin resistance
por: Su, Yinjie, et al.
Publicado: (2019)

HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer: HMGB1-mediated autophagy promotes gefitinib resistance
por: Lei, Tianyao, et al.
Publicado: (2022)

Exosomal HMGB1 Promoted Cancer Malignancy
por: Wang, Jiaan-Der, et al.
Publicado: (2021)

TRIB2 contributes to cisplatin resistance in small cell lung cancer
por: Liang, Yuanxin, et al.
Publicado: (2017)

Elevated Glutathione Peroxidase 2 Expression Promotes Cisplatin Resistance in Lung Adenocarcinoma
por: Du, He, et al.
Publicado: (2020)

Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS-mutated lung cancer cells
por: Wang, Mei, et al.
Publicado: (2022)

Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines
por: Chavez-Dominguez, Rodolfo L., et al.
Publicado: (2021)

FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
por: He, Lingfeng, et al.
Publicado: (2017)

FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
por: He, Lingfeng, et al.
Publicado: (2017)

Elevated N-Glycosylation Contributes to the Cisplatin Resistance of Non-Small Cell Lung Cancer Cells Revealed by Membrane Proteomic and Glycoproteomic Analysis
por: Zeng, Wenjuan, et al.
Publicado: (2021)

Increased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer
por: Cui, Yong, et al.
Publicado: (2018)

LNX1 Contributes to Cell Cycle Progression and Cisplatin Resistance
por: Jang, Minsu, et al.
Publicado: (2021)

Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer
por: Ma, Yu-Shui, et al.
Publicado: (2021)

HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma
por: Pan, Banzhou, et al.
Publicado: (2014)

Elevated branched-chain amino acid promotes atherosclerosis progression by enhancing mitochondrial-to-nuclear H(2)O(2)-disulfide HMGB1 in macrophages
por: Zhao, Shuai, et al.
Publicado: (2023)

Elevated TRIM23 expression predicts cisplatin resistance in lung adenocarcinoma
por: Zhang, Youwei, et al.
Publicado: (2020)

LncRNA SNHG7 promotes non-small cell lung cancer progression and cisplatin resistance by inducing autophagic activity
por: She, Kelin, et al.
Publicado: (2023)

LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis
por: Liu, Yanjie, et al.
Publicado: (2020)

CircEPSTI1 Promotes the Progression of Non-Small Cell Lung Cancer Through miR-145/HMGB3 Axis
por: Xie, Yuanyuan, et al.
Publicado: (2020)

HMGB1 overexpression promotes a malignant phenotype and radioresistance in ESCC
por: Dong, Jing, et al.
Publicado: (2022)

Upregulation of SPP1 Is a Marker for Poor Lung Cancer Prognosis and Contributes to Cancer Progression and Cisplatin Resistance
por: Tang, Huaping, et al.
Publicado: (2021)

LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma
por: Wang, Junbin, et al.
Publicado: (2020)

Association between an elevated level of HMGB1 and non-small-cell lung cancer: a meta-analysis and literature review
por: Xia, Quansong, et al.
Publicado: (2016)

HMGB1 bound to cisplatin–DNA adducts undergoes extensive acetylation and phosphorylation in vivo
por: He, Yafeng, et al.
Publicado: (2015)

Self-enforcing HMGB1/NF-κB/HIF-1α Feedback Loop Promotes Cisplatin Resistance in Hepatocellular Carcinoma Cells
por: Song, Yang, et al.
Publicado: (2020)

CDH13 promoter methylation regulates cisplatin resistance of non-small cell lung cancer cells
por: Wang, Yan, et al.
Publicado: (2018)

Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis
por: Xu, Jie, et al.
Publicado: (2014)

Demethoxycurcumin increases the sensitivity of cisplatin-resistant non-small lung cancer cells to cisplatin and induces apoptosis by activating the caspase signaling pathway
por: Chen, Yun, et al.
Publicado: (2020)

YAP promotes autophagy and progression of gliomas via upregulating HMGB1
por: Zhao, Min, et al.
Publicado: (2021)

LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma [Retraction]
Publicado: (2023)

Morin Hydrate Reverses Cisplatin Resistance by Impairing PARP1/HMGB1-Dependent Autophagy in Hepatocellular Carcinoma
por: Singh, Mahendra Pal, et al.
Publicado: (2019)

Elevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer Cells
por: Yan, Fei, et al.
Publicado: (2016)

Downregulated miR‐144‐3p contributes to progression of lung adenocarcinoma through elevating the expression of EZH2
por: Liu, Chao, et al.
Publicado: (2018)

HMGB1 Promotes Myeloid Egress and Limits Lymphatic Clearance of Malignant Pleural Effusions
por: Soloff, Adam C., et al.
Publicado: (2020)

The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling
por: Wu, Dong-ming, et al.
Publicado: (2019)

New Insights into the Role of HMGB2 in ST-Segment Elevation Myocardial Infarction
por: Qin, Hao, et al.
Publicado: (2023)

HMGB3 is Associated With an Unfavorable Prognosis of Neuroblastoma and Promotes Tumor Progression by Mediating TPX2
por: Zhong, Xiaodan, et al.
Publicado: (2021)

HMGB1‐Promoted Neutrophil Extracellular Traps Contribute to Cardiac Diastolic Dysfunction in Mice
por: Zhang, Xin‐Lin, et al.
Publicado: (2022)

EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations
por: Gao, Jing, et al.
Publicado: (2016)

HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma
por: Wang, Yanbin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sp657n6da0t57vc1e7ed2rf31v